0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Companion Animal Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30Q6781
Home | Market Reports | Pets & Animals
Global Companion Animal Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Companion Animal Drugs Market Research Report 2025

Code: QYRE-Auto-30Q6781
Report
September 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Companion Animal Drugs Market Size

The global market for Companion Animal Drugs was valued at US$ 29150 million in the year 2024 and is projected to reach a revised size of US$ 35270 million by 2031, growing at a CAGR of 2.8% during the forecast period.

Companion Animal Drugs Market

Companion Animal Drugs Market

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.
This report aims to provide a comprehensive presentation of the global market for Companion Animal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Drugs.
The Companion Animal Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Companion Animal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Animal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Companion Animal Drugs Market Report

Report Metric Details
Report Name Companion Animal Drugs Market
Accounted market size in year US$ 29150 million
Forecasted market size in 2031 US$ 35270 million
CAGR 2.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Dogs
  • Cats
  • Horses
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zoetis, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Vetoquinol, Virbac, Dechra Pharmaceuticals, Ceva Sante Animale, Aratana Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Companion Animal Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Companion Animal Drugs Market growing?

Ans: The Companion Animal Drugs Market witnessing a CAGR of 2.8% during the forecast period 2025-2031.

What is the Companion Animal Drugs Market size in 2031?

Ans: The Companion Animal Drugs Market size in 2031 will be US$ 35270 million.

What is the Companion Animal Drugs Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Companion Animal Drugs Market report?

Ans: The main players in the Companion Animal Drugs Market are Zoetis, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Vetoquinol, Virbac, Dechra Pharmaceuticals, Ceva Sante Animale, Aratana Therapeutics

What are the Application segmentation covered in the Companion Animal Drugs Market report?

Ans: The Applications covered in the Companion Animal Drugs Market report are Dogs, Cats, Horses, Others

What are the Type segmentation covered in the Companion Animal Drugs Market report?

Ans: The Types covered in the Companion Animal Drugs Market report are Antibiotics and Antimicrobials, Parasiticides, Others

Recommended Reports

Animal Health Drugs

Pet Healthcare Devices

Pet Nutrition & Management

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibiotics and Antimicrobials
1.2.3 Parasiticides
1.2.4 Others
1.3 Market by Application
1.3.1 Global Companion Animal Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Drugs Market Perspective (2020-2031)
2.2 Global Companion Animal Drugs Growth Trends by Region
2.2.1 Global Companion Animal Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Companion Animal Drugs Historic Market Size by Region (2020-2025)
2.2.3 Companion Animal Drugs Forecasted Market Size by Region (2026-2031)
2.3 Companion Animal Drugs Market Dynamics
2.3.1 Companion Animal Drugs Industry Trends
2.3.2 Companion Animal Drugs Market Drivers
2.3.3 Companion Animal Drugs Market Challenges
2.3.4 Companion Animal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Drugs Players by Revenue
3.1.1 Global Top Companion Animal Drugs Players by Revenue (2020-2025)
3.1.2 Global Companion Animal Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Companion Animal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Companion Animal Drugs Revenue
3.4 Global Companion Animal Drugs Market Concentration Ratio
3.4.1 Global Companion Animal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Drugs Revenue in 2024
3.5 Global Key Players of Companion Animal Drugs Head office and Area Served
3.6 Global Key Players of Companion Animal Drugs, Product and Application
3.7 Global Key Players of Companion Animal Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Drugs Breakdown Data by Type
4.1 Global Companion Animal Drugs Historic Market Size by Type (2020-2025)
4.2 Global Companion Animal Drugs Forecasted Market Size by Type (2026-2031)
5 Companion Animal Drugs Breakdown Data by Application
5.1 Global Companion Animal Drugs Historic Market Size by Application (2020-2025)
5.2 Global Companion Animal Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Companion Animal Drugs Market Size (2020-2031)
6.2 North America Companion Animal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Companion Animal Drugs Market Size by Country (2020-2025)
6.4 North America Companion Animal Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Animal Drugs Market Size (2020-2031)
7.2 Europe Companion Animal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Companion Animal Drugs Market Size by Country (2020-2025)
7.4 Europe Companion Animal Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Drugs Market Size (2020-2031)
8.2 Asia-Pacific Companion Animal Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Companion Animal Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Companion Animal Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Animal Drugs Market Size (2020-2031)
9.2 Latin America Companion Animal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Companion Animal Drugs Market Size by Country (2020-2025)
9.4 Latin America Companion Animal Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Drugs Market Size (2020-2031)
10.2 Middle East & Africa Companion Animal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Companion Animal Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Companion Animal Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Drugs Introduction
11.1.4 Zoetis Revenue in Companion Animal Drugs Business (2020-2025)
11.1.5 Zoetis Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Companion Animal Drugs Introduction
11.2.4 Bayer Revenue in Companion Animal Drugs Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Companion Animal Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Companion Animal Drugs Introduction
11.4.4 Eli Lilly Revenue in Companion Animal Drugs Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Companion Animal Drugs Introduction
11.5.4 Merck Revenue in Companion Animal Drugs Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Vetoquinol
11.6.1 Vetoquinol Company Details
11.6.2 Vetoquinol Business Overview
11.6.3 Vetoquinol Companion Animal Drugs Introduction
11.6.4 Vetoquinol Revenue in Companion Animal Drugs Business (2020-2025)
11.6.5 Vetoquinol Recent Development
11.7 Virbac
11.7.1 Virbac Company Details
11.7.2 Virbac Business Overview
11.7.3 Virbac Companion Animal Drugs Introduction
11.7.4 Virbac Revenue in Companion Animal Drugs Business (2020-2025)
11.7.5 Virbac Recent Development
11.8 Dechra Pharmaceuticals
11.8.1 Dechra Pharmaceuticals Company Details
11.8.2 Dechra Pharmaceuticals Business Overview
11.8.3 Dechra Pharmaceuticals Companion Animal Drugs Introduction
11.8.4 Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2020-2025)
11.8.5 Dechra Pharmaceuticals Recent Development
11.9 Ceva Sante Animale
11.9.1 Ceva Sante Animale Company Details
11.9.2 Ceva Sante Animale Business Overview
11.9.3 Ceva Sante Animale Companion Animal Drugs Introduction
11.9.4 Ceva Sante Animale Revenue in Companion Animal Drugs Business (2020-2025)
11.9.5 Ceva Sante Animale Recent Development
11.10 Aratana Therapeutics
11.10.1 Aratana Therapeutics Company Details
11.10.2 Aratana Therapeutics Business Overview
11.10.3 Aratana Therapeutics Companion Animal Drugs Introduction
11.10.4 Aratana Therapeutics Revenue in Companion Animal Drugs Business (2020-2025)
11.10.5 Aratana Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Companion Animal Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antibiotics and Antimicrobials
 Table 3. Key Players of Parasiticides
 Table 4. Key Players of Others
 Table 5. Global Companion Animal Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Companion Animal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Companion Animal Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Companion Animal Drugs Market Share by Region (2020-2025)
 Table 9. Global Companion Animal Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Companion Animal Drugs Market Share by Region (2026-2031)
 Table 11. Companion Animal Drugs Market Trends
 Table 12. Companion Animal Drugs Market Drivers
 Table 13. Companion Animal Drugs Market Challenges
 Table 14. Companion Animal Drugs Market Restraints
 Table 15. Global Companion Animal Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Companion Animal Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Companion Animal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Drugs as of 2024)
 Table 18. Ranking of Global Top Companion Animal Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Companion Animal Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Companion Animal Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Companion Animal Drugs, Product and Application
 Table 22. Global Key Players of Companion Animal Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Companion Animal Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Companion Animal Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Companion Animal Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Companion Animal Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Companion Animal Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Companion Animal Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Companion Animal Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Companion Animal Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Companion Animal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Companion Animal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Companion Animal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Companion Animal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Companion Animal Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Companion Animal Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Companion Animal Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Companion Animal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Companion Animal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Companion Animal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Companion Animal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Zoetis Company Details
 Table 48. Zoetis Business Overview
 Table 49. Zoetis Companion Animal Drugs Product
 Table 50. Zoetis Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 51. Zoetis Recent Development
 Table 52. Bayer Company Details
 Table 53. Bayer Business Overview
 Table 54. Bayer Companion Animal Drugs Product
 Table 55. Bayer Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 56. Bayer Recent Development
 Table 57. Boehringer Ingelheim Company Details
 Table 58. Boehringer Ingelheim Business Overview
 Table 59. Boehringer Ingelheim Companion Animal Drugs Product
 Table 60. Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 61. Boehringer Ingelheim Recent Development
 Table 62. Eli Lilly Company Details
 Table 63. Eli Lilly Business Overview
 Table 64. Eli Lilly Companion Animal Drugs Product
 Table 65. Eli Lilly Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 66. Eli Lilly Recent Development
 Table 67. Merck Company Details
 Table 68. Merck Business Overview
 Table 69. Merck Companion Animal Drugs Product
 Table 70. Merck Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 71. Merck Recent Development
 Table 72. Vetoquinol Company Details
 Table 73. Vetoquinol Business Overview
 Table 74. Vetoquinol Companion Animal Drugs Product
 Table 75. Vetoquinol Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 76. Vetoquinol Recent Development
 Table 77. Virbac Company Details
 Table 78. Virbac Business Overview
 Table 79. Virbac Companion Animal Drugs Product
 Table 80. Virbac Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 81. Virbac Recent Development
 Table 82. Dechra Pharmaceuticals Company Details
 Table 83. Dechra Pharmaceuticals Business Overview
 Table 84. Dechra Pharmaceuticals Companion Animal Drugs Product
 Table 85. Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 86. Dechra Pharmaceuticals Recent Development
 Table 87. Ceva Sante Animale Company Details
 Table 88. Ceva Sante Animale Business Overview
 Table 89. Ceva Sante Animale Companion Animal Drugs Product
 Table 90. Ceva Sante Animale Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 91. Ceva Sante Animale Recent Development
 Table 92. Aratana Therapeutics Company Details
 Table 93. Aratana Therapeutics Business Overview
 Table 94. Aratana Therapeutics Companion Animal Drugs Product
 Table 95. Aratana Therapeutics Revenue in Companion Animal Drugs Business (2020-2025) & (US$ Million)
 Table 96. Aratana Therapeutics Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Companion Animal Drugs Picture
 Figure 2. Global Companion Animal Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Companion Animal Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Antibiotics and Antimicrobials Features
 Figure 5. Parasiticides Features
 Figure 6. Others Features
 Figure 7. Global Companion Animal Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Companion Animal Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Dogs Case Studies
 Figure 10. Cats Case Studies
 Figure 11. Horses Case Studies
 Figure 12. Others Case Studies
 Figure 13. Companion Animal Drugs Report Years Considered
 Figure 14. Global Companion Animal Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Companion Animal Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Companion Animal Drugs Market Share by Region: 2024 VS 2031
 Figure 17. Global Companion Animal Drugs Market Share by Players in 2024
 Figure 18. Global Top Companion Animal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Drugs as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Companion Animal Drugs Revenue in 2024
 Figure 20. North America Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Companion Animal Drugs Market Share by Country (2020-2031)
 Figure 22. United States Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Companion Animal Drugs Market Share by Country (2020-2031)
 Figure 26. Germany Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Companion Animal Drugs Market Share by Region (2020-2031)
 Figure 34. China Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Companion Animal Drugs Market Share by Country (2020-2031)
 Figure 42. Mexico Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Companion Animal Drugs Market Share by Country (2020-2031)
 Figure 46. Turkey Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Companion Animal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Zoetis Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 50. Bayer Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 51. Boehringer Ingelheim Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 52. Eli Lilly Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 54. Vetoquinol Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 55. Virbac Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 56. Dechra Pharmaceuticals Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 57. Ceva Sante Animale Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 58. Aratana Therapeutics Revenue Growth Rate in Companion Animal Drugs Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS